Jane L. Burns - Concepedia

Author

Jane L. Burns

Also Known As

Gibson, Ronald L., J Burns, J L Burns, J. Burns, J. L Burns, J. L. Burns, J.L. Burns, JANE L. BURNS, Jane Burns, Jane L Burns

181

Publications

17.9K

Citations

H-Index

115

Concepts

All Affiliations

University of Washington Seattle Children's Hospital University of Colorado Denver Columbia University

About

Jane L. Burns is an author at University of Washington specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	65	8.2K
2	Health Sciences	15	18	2K
3	Engineering	3	3	385
4	Natural Sciences	1	1	71
5	Public Health	1	1	11

Jane L. Burns

122

Publications

15.3K

Citations

H-Index

Page 1

	Year	Citations
Genetic adaptation by <i>Pseudomonas aeruginosa</i> to the airways of cystic fibrosis patients Eric E. Smith, Danielle Buckley, Zaining Wu, Proceedings of the National Academy of Sciences ImmunologyBacterial PathogensMedical MicrobiologyDisease SusceptibilityP. Aeruginosa	2006	1.3K
Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa Lisa Saiman, Bruce C. Marshall, Nicole Mayer-Hamblett, JAMA	2003	952
Emergence of <i>Pseudomonas aeruginosa</i> Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis Lawrence Mulcahy, Jane L. Burns, Stephen Lory, Journal of Bacteriology Pathogenic MicrobiologyMicrobial PathogensBacteriologyBacterial PathogensCf Infection	2010	619
Longitudinal Assessment of<i>Pseudomonas aeruginosa</i>in Young Children with Cystic Fibrosis Jane L. Burns, Ronald L. Gibson, Sharon McNamara, The Journal of Infectious Diseases AntibioticsMedicinePediatricsRespiratory InfectionPediatric Lung Disease	2001	556
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway <i>Pseudomonas aeruginosa</i> Robert K. Ernst, Eugene C. Yi, Lin Guo, Science Medical MicrobiologyHealth SciencesBiochemistryLung InflammationAntibiotics	1999	484
Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States Jane L. Burns, Julia Emerson, Jenny R. Stapp, Clinical Infectious Diseases Medical MicrobiologyPathogenic MicrobiologyCf SpecimensAntimicrobial SusceptibilityMicrobial Disease	1998	420
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis* Margaret Rosenfeld, Ronald L. Gibson, Sharon McNamara, Pediatric Pulmonology	2001	392
Clinically Feasible Biofilm Susceptibility Assay for Isolates of <i>Pseudomonas aeruginosa</i> from Patients with Cystic Fibrosis Samuel M. Moskowitz, Jessica M. Foster, Julia Emerson, Journal of Clinical Microbiology	2004	386
Growth phenotypes of <i>Pseudomonas aeruginosa lasR</i> mutants adapted to the airways of cystic fibrosis patients David A. D’Argenio, Manhong Wu, Lucas R. Hoffman, Molecular Microbiology	2007	348
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis Ronald L. Gibson, Julia Emerson, Sharon McNamara, American Journal of Respiratory and Critical Care Medicine AntibioticsInhaled TobramycinPediatricsRespiratory InfectionPediatric Lung Disease	2003	314

Page 1